Wei-Wu He - 16 Jun 2025 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
Wei-Wu He
Reporting Manager
WEI-WU HE, Ph.D.
Security
CASI Pharmaceuticals, Inc. Ordinary Shares
Symbol
CASI
Shares outstanding
15.7M shares
Disclosed Ownership
3.74M shares
Ownership
23.8%
Form type
SCHEDULE 13D/A
Filing time
20 Jun 2025, 16:30:40 UTC
Date of event
16 Jun 2025
Next filing
18 Dec 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
WEI-WU HE, Ph.D. 23.8% 3.74M 2.13M 1.6M /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D. 0001542073
HUIYING MEMORIAL FOUNDATION 2.6% 408K 0 408K /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./President
EMERGING TECHNOLOGY PARTNERS, LLC 7.1% 1.1M 0 1.1M /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./ Managing Member
ETP Global Fund L.P. 4.9% 753K 0 753K EMERGING TECHNOLOGY PARTNERS, LLC General Partner
ETP BIOHEALTH III FUND , L.P. 1.9% 300K 0 300K EMERGING TECHNOLOGY PARTNERS, LLC General Partner
HE Family GRAT 0.6% 100K 0 100K /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./Trustee